240 related articles for article (PubMed ID: 36062610)
21. The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
Sharma D; Shah RJ; Sreenivasan J; Kafle P; Gupta R; Levine A; Lanier GM; Aronow WS
Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):543-547. PubMed ID: 35726644
[TBL] [Abstract][Full Text] [Related]
22. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
Lyle MA; Fenstad ER; McGoon MD; Frantz RP; Krowka MJ; Kane GC; Swanson KL
Chest; 2016 Feb; 149(2):362-371. PubMed ID: 26204445
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
Rajaram S; Swift AJ; Capener D; Elliot CA; Condliffe R; Davies C; Hill C; Hurdman J; Kidling R; Akil M; Wild JM; Kiely DG
J Rheumatol; 2012 Jun; 39(6):1265-74. PubMed ID: 22589263
[TBL] [Abstract][Full Text] [Related]
25. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
Choi JH; Joo SJ; Kim J
Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
[TBL] [Abstract][Full Text] [Related]
26. A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance.
Chubuchny V; Pugliese NR; Taddei C; Poggianti E; Spini V; Barison A; Formichi B; Airò E; Bauleo C; Prediletto R; Pastormerlo LE; Coceani M; Ciardetti M; Petersen C; Pasanisi E; Lombardi C; Emdin M; Giannoni A
ESC Heart Fail; 2021 Apr; 8(2):1216-1229. PubMed ID: 33566429
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
[TBL] [Abstract][Full Text] [Related]
28. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure.
Colin GC; Gerber BL; de Meester de Ravenstein C; Byl D; Dietz A; Kamga M; Pasquet A; Vancraeynest D; Vanoverschelde JL; D'Hondt AM; Ghaye B; Pouleur AC
Eur Radiol; 2018 Nov; 28(11):4643-4653. PubMed ID: 29761362
[TBL] [Abstract][Full Text] [Related]
30. Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.
Grapsa J; Pereira Nunes MC; Tan TC; Cabrita IZ; Coulter T; Smith BC; Dawson D; Gibbs JS; Nihoyannopoulos P
Circ Cardiovasc Imaging; 2015 Jun; 8(6):. PubMed ID: 26063743
[TBL] [Abstract][Full Text] [Related]
31. [Investigation and analysis for current situation and pathogenesis relevant to pulmonary hypertension].
Lei S; Tang D; Xu N; Wu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):641-646. PubMed ID: 28690220
[TBL] [Abstract][Full Text] [Related]
32. A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.
Berthelot E; Montani D; Algalarrondo V; Dreyfuss C; Rifai R; Benmalek A; Jais X; Bouchachi A; Savale L; Simonneau G; Chemla D; Humbert M; Sitbon O; Assayag P
J Card Fail; 2017 Jan; 23(1):29-35. PubMed ID: 27742455
[TBL] [Abstract][Full Text] [Related]
33. The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.
Ptaszyńska-Kopczyńska K; Krentowska A; Sawicka E; Skoneczny A; Jasiewicz M; Knapp M; Musiał WJ; Sobkowicz B; Kamiński KA
Adv Med Sci; 2017 Mar; 62(1):39-44. PubMed ID: 28187374
[TBL] [Abstract][Full Text] [Related]
34. Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia.
Singh A; Feingold B; Rivera-Lebron B; Weiner D; Drant S
J Perinatol; 2019 Sep; 39(9):1282-1290. PubMed ID: 31312036
[TBL] [Abstract][Full Text] [Related]
35. Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.
Rosenzweig EB; Bates A; Mullen MP; Abman SH; Austin ED; Everett A; Fineman J; Feinstein J; Hopper RK; Kinsella JP; Krishnan US; Lu M; Mandl KD; Raj JU; Varghese N; Yung D; Handler SS; Sleeper LA
Ann Am Thorac Soc; 2022 Jun; 19(6):1000-1012. PubMed ID: 35049414
[No Abstract] [Full Text] [Related]
36. Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure.
Vitarelli A; Mangieri E; Terzano C; Gaudio C; Salsano F; Rosato E; Capotosto L; D'Orazio S; Azzano A; Truscelli G; Cocco N; Ashurov R
J Am Heart Assoc; 2015 Mar; 4(3):e001584. PubMed ID: 25792128
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.
Mahran Y; Schueler R; Weber M; Pizarro C; Nickenig G; Skowasch D; Hammerstingl C
World J Cardiol; 2016 Aug; 8(8):472-80. PubMed ID: 27621775
[TBL] [Abstract][Full Text] [Related]
38. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
39. Complications of Right Heart Catheterization in Patients ≥70 Years of Age With Suspected Pulmonary Hypertension: Experience From a Tertiary Care Center.
Cueto-Robledo G; González-Hermosillo LM; Porres-Aguilar M; Navarro-Vergara DI; Garcia-Cesar M; Torres-Rojas MB; Martinez-Carrillo AD; Cajigas HR
Curr Probl Cardiol; 2024 Feb; 49(2):102136. PubMed ID: 37858849
[TBL] [Abstract][Full Text] [Related]
40. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
